Product Information
COMPLERA TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $130.3142 per EA under NDC 61958110101. Its NADAC has been published 657 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
COMPLERA TABLET
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarateStrength
200; 25; 300 mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958110101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA202123FDA Approved
8/10/2011
TE Code
AB
On Market Since
8/10/2011
Pharmacological Classes
Price Statistics
The NADAC for COMPLERA TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 109.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $130.3142 per EA |
|---|---|
| All-time high | $130.5185 (May 13, 2026) |
| All-time low | $62.2608 (Dec 18, 2013) |
| 52-week high | $130.5185 |
| 52-week low | $124.3546 |
| Median price | $95.1771 |
| Average price | $95.6836 |
| Largest weekly change | +6.9% (Jan 13, 2016) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COMPLERA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COMPLERA TABLET, manufactured by Gilead Sciences, Inc., is $130.3142 per EA (NDC 61958110101), effective Aug 19, 2026.
How has the price of COMPLERA TABLET changed over time?
Over the history we have for it, the NADAC for COMPLERA TABLET has risen 109.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for COMPLERA TABLET?
Since Nov 28, 2013, the NADAC for COMPLERA TABLET has ranged from a low of $62.2608 (Dec 18, 2013) to a high of $130.5185 (May 13, 2026), with a median of $95.1771 per EA.
Are there cheaper alternatives to COMPLERA TABLET?
No other NADAC-published product currently shares the active ingredient and strength of COMPLERA TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COMPLERA TABLET?
COMPLERA TABLET (NDC 61958110101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.